CHEST Guidelines-Economic-Burden-of-COPD-in-the-Presence-of-Comorbi (1)

Economic-Burden-of-COPD-in-the-Presence-of-Comorbi (1)

Pdf Summary

The study "Economic Burden of COPD in the Presence of Comorbidities" led by David M. Mannino and his colleagues, examines the increased economic costs and health resource use among COPD patients who also suffer from additional health conditions. The researchers conducted a retrospective analysis using data from the Truven Health MarketScan Commercial and the Medicare Supplemental Databases, covering the period from January 2009 to September 2012. The study involved 183,681 COPD patients and assessed healthcare resource utilization and costs one year from the initial COPD diagnosis.<br /><br />The research found that the common comorbidities among COPD patients included cardiovascular disease (34.8%), diabetes (22.8%), asthma (14.7%), and anemia (14.2%). The presence of these comorbidities significantly increased the total healthcare costs, with chronic kidney disease (CKD) and anemia causing the highest cost impacts. Anemia was particularly notable, increasing healthcare costs by an average of $10,762 per patient. Asthma resulted in the highest COPD- or asthma-related healthcare costs among comorbidities. <br /><br />The study concludes that there is a substantial economic burden associated with managing COPD alongside other comorbidities. Such conditions lead to higher healthcare utilization, including more frequent emergency room visits and hospitalizations, contributing heavily to the overall healthcare costs. The findings underscore the importance of identifying and managing comorbid conditions in patients with COPD to help mitigate the economic impact and improve patient outcomes. Future research should focus on the role of comorbidities in COPD pathogenesis and strategies to enhance care for patients with multiple health issues.

Keywords

COPD

comorbidities

economic burden

healthcare costs

David M. Mannino

Truven Health MarketScan

cardiovascular disease

anemia

chronic kidney disease

healthcare utilization